Tempest Therapeutics, Inc. (TPST): Submission of Matters to a Vote of Security Holders
Tempest Therapeutics, Inc. (TPST) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. The information disclosed in Item 8.01 of this Current Report on Form 8-K is incorporated herein by reference. Item 8.01. Other Events. On October 14, 2026, Tempest Therapeutics, Inc. (the “Company”) called to order
How this was made
The 30-second read
Why it matters
The filing itself does not change valuation; the market will react once voting results are known.
Market read
Low immediate relevance; primary impact will depend on the outcome of the November 12 vote.
What to watch
The involvement of proxy solicitation firm Sodali & Co. may indicate a close race for the required 75% approval.
Background
Tempest Therapeutics (TPST) filed an 8‑K to announce the reconvening of a special shareholder meeting to vote on a charter amendment that would change supermajority voting requirements.
Ticker impact
SEC 8‑K filing reconvening a special meeting to vote on a charter amendment; no vote outcome yet.
likely little movement as investors await the November 12 vote result
Proxy solicitations are routine; without a clear result the market typically remains unchanged.
Market effects
Minimal; governance change could set a precedent for other biotech firms seeking voting rule adjustments.
None
None
Counterpoint
If the amendment passes, it could tighten voting thresholds, potentially deterring activist investors and supporting long‑term shareholders.
Key entities
- companyTempest Therapeutics, Inc.
Biotech firm seeking shareholder approval for charter amendment.
- service_providerSodali & Co.
Proxy solicitation firm assisting Tempest with the vote.